IS5524A - Forðatöflur til inntöku - Google Patents

Forðatöflur til inntöku

Info

Publication number: IS5524A
Authority: IS; Iceland
Prior art keywords: release tablets; oral prolonged; prolonged; oral; tablets
Prior art date: 1997-12-22

Application number

IS5524A

Other languages

English (en)

Inventor

Karehill Per-Gunnar

Johan Lundberg Per

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-22

Filing date

2000-06-08

Publication date

2000-06-08

2000-06-08 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2000-06-08 Publication of IS5524A publication Critical patent/IS5524A/is

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IS5524A 1997-12-22 2000-06-08 Forðatöflur til inntöku IS5524A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9704869A SE9704869D0 (sv)	1997-12-22	1997-12-22	New pharmaceutical formulaton II
PCT/SE1998/002368 WO1999032091A1 (en)	1997-12-22	1998-12-17	Oral pharmaceutical extended release dosage form

Publications (1)

Publication Number	Publication Date
IS5524A true IS5524A (is)	2000-06-08

Family

ID=20409571

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5524A IS5524A (is)	1997-12-22	2000-06-08	Forðatöflur til inntöku

Country Status (39)

Country	Link
US (1)	US6605303B1 (is)
EP (1)	EP1043976B1 (is)
JP (1)	JP4865945B2 (is)
KR (2)	KR20060097069A (is)
CN (1)	CN1171582C (is)
AR (1)	AR017201A1 (is)
AT (1)	ATE312602T1 (is)
AU (1)	AU759634B2 (is)
BG (1)	BG65028B1 (is)
BR (1)	BR9814378A (is)
CA (1)	CA2315261C (is)
CY (1)	CY1106072T1 (is)
CZ (1)	CZ299228B6 (is)
DE (1)	DE69832816T2 (is)
DK (1)	DK1043976T3 (is)
DZ (1)	DZ2685A1 (is)
EE (1)	EE04901B1 (is)
ES (1)	ES2252875T3 (is)
HK (1)	HK1034455A1 (is)
HR (1)	HRP20000380B1 (is)
HU (1)	HUP0101437A3 (is)
IL (2)	IL136827A0 (is)
IS (1)	IS5524A (is)
MA (1)	MA26576A1 (is)
MY (1)	MY126555A (is)
NO (1)	NO20003218L (is)
NZ (1)	NZ505127A (is)
PL (1)	PL193776B1 (is)
RU (1)	RU2214232C2 (is)
SA (1)	SA99191077B1 (is)
SE (1)	SE9704869D0 (is)
SK (1)	SK284988B6 (is)
TN (1)	TNSN98229A1 (is)
TR (1)	TR200001981T2 (is)
TW (1)	TWI249410B (is)
UA (1)	UA69397C2 (is)
WO (1)	WO1999032091A1 (is)
YU (1)	YU36700A (is)
ZA (1)	ZA9811239B (is)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL186605B1 (pl) *	1995-09-21	2004-01-30	Pharma Pass Llc	Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
ATE500815T1 (de)	1997-12-08	2011-03-15	Dietrich Rango	Neue suppositoriumsform mit säureempfindlichem wirkstoff
FR2774288B1 (fr) *	1998-01-30	2001-09-07	Ethypharm Sa	Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
ZA9810765B (en) *	1998-05-28	1999-08-06	Ranbaxy Lab Ltd	Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
FR2793688B1 (fr)	1999-05-21	2003-06-13	Ethypharm Lab Prod Ethiques	Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
US7029701B2 (en) *	2000-09-11	2006-04-18	Andrx Pharmaceuticals, Llc	Composition for the treatment and prevention of ischemic events
WO2002032427A1 (en) *	2000-10-20	2002-04-25	Galephar M/F	Stable oral formulation containing benzimidazole derivative
JP2004514737A (ja) *	2000-12-07	2004-05-20	アルタナ　ファルマ　アクチエンゲゼルシャフト	酸分解性活性成分を含有する迅速に崩壊する錠剤
JP4848101B2 (ja) *	2001-08-17	2011-12-28	株式会社フジモト・コーポレーション	徐放性マイクロペレット
PT1492511E (pt)	2002-04-09	2009-04-09	Flamel Tech Sa	Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
TW200410955A (en)	2002-07-29	2004-07-01	Altana Pharma Ag	Novel salt of (S)-PANTOPRAZOLE
WO2004028567A1 (ja) *	2002-09-26	2004-04-08	Yamanouchi Pharmaceutical Co., Ltd.	薬物吸収性改善剤
EP1552833B1 (en)	2002-10-16	2016-12-28	Takeda Pharmaceutical Company Limited	Process for producing an amorphous optically active isomer of lansoprazole
MY148805A (en)	2002-10-16	2013-05-31	Takeda Pharmaceutical	Controlled release preparation
JP4493970B2 (ja) *	2002-10-16	2010-06-30	武田薬品工業株式会社	持続性製剤
CA2519208A1 (en) *	2003-03-17	2004-09-30	Takeda Pharmaceutical Company Limited	Controlled release composition
JP4933033B2 (ja) *	2003-03-17	2012-05-16	武田薬品工業株式会社	放出制御組成物
PE20050150A1 (es) *	2003-05-08	2005-03-22	Altana Pharma Ag	Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) *	2003-05-08	2005-03-04	Altana Pharma Ag	Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2005012289A1 (en) *	2003-07-17	2005-02-10	Altana Pharma Ag	Novel salt of (r) - pantoprazole
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) *	2003-10-01	2012-09-11	Wyeth Corp	Pantoprazole multiparticulate formulations
FR2861990B1 (fr) *	2003-11-10	2006-02-10	Nouveaux Produits Pharma	Comprimes faiblement doses a reseau de polymeres
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2469427A1 (en) *	2004-06-01	2005-12-01	Pharmascience Inc.	Dry mixed dosage form containing benzimidazole derivatives
US8461187B2 (en)	2004-06-16	2013-06-11	Takeda Pharmaceuticals U.S.A., Inc.	Multiple PPI dosage form
WO2006082523A2 (en) *	2005-01-25	2006-08-10	Aurobindo Pharma Limited	Pharmaceutical sustained release composition of metformin
KR100591142B1 (ko) *	2005-11-04	2006-06-20	지엘팜텍 주식회사	파록세틴을 활성물질로 함유하는 장용성 서방형 정제
DE102005060393A1 (de) *	2005-12-16	2007-06-21	Add Advanced Drug Delivery Technologies Ltd.	Orales Präparat mit kontrollierter Freisetzung
KR20080081071A (ko) *	2005-12-28	2008-09-05	다케다 야쿠힌 고교 가부시키가이샤	방출 제어 고형 제제
EP2026768B1 (en) *	2006-06-01	2018-02-28	Dexcel Pharma Technologies Ltd.	Multiple unit pharmaceutical formulation
WO2008094877A2 (en) *	2007-01-30	2008-08-07	Drugtech Corporation	Compositions for oral delivery of pharmaceuticals
WO2008112388A1 (en)	2007-03-14	2008-09-18	Drugtech Corporation	Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
JP5629581B2 (ja) *	2007-10-12	2014-11-19	タケダファーマシューティカルズユー．エス．エー．インコーポレイティド	食物の摂取から独立した消化器疾患の治療方法
US12011423B2 (en)	2007-11-06	2024-06-18	Foraviset Ltd.	S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
JP5592902B2 (ja)	2009-03-09	2014-09-17	カウンシルオブサイエンティフィックアンドインダストリアルリサーチ	治療薬の徐放性組成物
US20140127296A1 (en) *	2012-11-05	2014-05-08	Kenneth John Tibbs	Pharmaceutical preparation and method for treatment of diabetes
US9050263B2 (en)	2013-02-13	2015-06-09	Redhill Biopharma Ltd.	Pharmaceutical compositions for the treatment of Helicobacter pylori
CN104721185A (zh) *	2013-12-21	2015-06-24	辰欣药业股份有限公司	一种提高埃索美拉唑钠稳定性的方法
EP3288556A4 (en)	2015-04-29	2018-09-19	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10736855B2 (en)	2016-02-25	2020-08-11	Dexcel Pharma Technologies Ltd.	Compositions comprising proton pump inhibitors
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
US10729735B1 (en)	2016-09-14	2020-08-04	Phoenix Biotechnology, Inc.	Method and compostitions for treating coronavirus infection
US11878011B2 (en)	2020-05-07	2024-01-23	Redhill Biopharma Ltd.	Method for eradicating Helicobacter pylori infection in patients regardless of body mass index

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
IL75400A (en) *	1984-06-16	1988-10-31	Byk Gulden Lomberg Chem Fab	Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU4640985A (en) *	1984-08-31	1986-03-06	Nippon Chemiphar Co. Ltd.	Benzimidazole derivatives
US5229181A (en) *	1990-10-30	1993-07-20	Amber Technologies	Tubular knit cleanroom wiper
TW209174B (is)	1991-04-19	1993-07-11	Takeda Pharm Industry Co Ltd
IT1251153B (it)	1991-08-06	1995-05-04	Vectorpharma Int	Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
ATE219933T1 (de) *	1992-09-18	2002-07-15	Yamanouchi Pharma Co Ltd	Hydrogelzubereitung mit verzögerter freisetzung
JPH06199657A (ja) *	1992-12-10	1994-07-19	Sumitomo Pharmaceut Co Ltd	徐放性製剤
SE9301830D0 (sv) *	1993-05-28	1993-05-28	Ab Astra	New compounds
JPH07330629A (ja) *	1994-06-02	1995-12-19	Nippon Shokubai Co Ltd	徐放性製剤
UA41946C2 (uk) *	1994-07-08	2001-10-15	Астра Актієболаг	Оральна фармацевтична складова одинична дозована форма у вигляді таблетки, спосіб її одержання, упаковка у вигляді блістера та спосіб інгібування секреції шлункової кислоти і/або лікування шлунково-кишкових запальних захворювань
WO1996001622A1 (en) *	1994-07-08	1996-01-25	Astra Aktiebolag	New oral pharmaceutical formulation containing magnesium salt of omeprazole
SE9500422D0 (sv) *	1995-02-06	1995-02-06	Astra Ab	New oral pharmaceutical dosage forms
US6132768A (en)	1995-07-05	2000-10-17	Byk Gulden Lomberg Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) *	1995-07-05	1999-08-31	Byk Gulden Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
SE9600071D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients I
WO1997047285A1 (en) *	1996-06-10	1997-12-18	Depomed, Inc.	Gastric-retentive oral controlled drug delivery system with enhanced retention properties
SE9602442D0 (sv) *	1996-06-20	1996-06-20	Astra Ab	Administration of pharmaceuticals
DE19626045C2 (de) *	1996-06-28	1998-12-03	Klinge Co Chem Pharm Fab	Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
US7016717B2 (en) *	2002-07-05	2006-03-21	The Regents Of The University Of California	Near-infrared spectroscopic tissue imaging for medical applications
ITPD20050230A1 (it) *	2005-07-28	2007-01-29	Marcato Spa	Macchina ad uso domestico per la estrusione di paste alimentari fresche

1997
- 1997-12-22 SE SE9704869A patent/SE9704869D0/xx unknown
1998
- 1998-12-08 ZA ZA9811239A patent/ZA9811239B/xx unknown
- 1998-12-09 TW TW087120440A patent/TWI249410B/zh not_active IP Right Cessation
- 1998-12-09 AR ARP980106244A patent/AR017201A1/es not_active Application Discontinuation
- 1998-12-11 MA MA25383A patent/MA26576A1/fr unknown
- 1998-12-16 DZ DZ980295A patent/DZ2685A1/xx active
- 1998-12-16 TN TNTNSN98229A patent/TNSN98229A1/fr unknown
- 1998-12-17 DE DE69832816T patent/DE69832816T2/de not_active Expired - Lifetime
- 1998-12-17 PL PL98341428A patent/PL193776B1/pl unknown
- 1998-12-17 CN CNB988136163A patent/CN1171582C/zh not_active Expired - Fee Related
- 1998-12-17 ES ES98964631T patent/ES2252875T3/es not_active Expired - Lifetime
- 1998-12-17 KR KR1020067016717A patent/KR20060097069A/ko not_active Application Discontinuation
- 1998-12-17 WO PCT/SE1998/002368 patent/WO1999032091A1/en not_active Application Discontinuation
- 1998-12-17 IL IL13682798A patent/IL136827A0/xx not_active IP Right Cessation
- 1998-12-17 BR BR9814378-6A patent/BR9814378A/pt not_active Application Discontinuation
- 1998-12-17 RU RU2000116011/14A patent/RU2214232C2/ru not_active IP Right Cessation
- 1998-12-17 JP JP2000525083A patent/JP4865945B2/ja not_active Expired - Fee Related
- 1998-12-17 YU YU36700A patent/YU36700A/sh unknown
- 1998-12-17 HU HU0101437A patent/HUP0101437A3/hu unknown
- 1998-12-17 SK SK807-2000A patent/SK284988B6/sk unknown
- 1998-12-17 TR TR2000/01981T patent/TR200001981T2/xx unknown
- 1998-12-17 CZ CZ20002314A patent/CZ299228B6/cs not_active IP Right Cessation
- 1998-12-17 EP EP98964631A patent/EP1043976B1/en not_active Expired - Lifetime
- 1998-12-17 AT AT98964631T patent/ATE312602T1/de not_active IP Right Cessation
- 1998-12-17 US US09/555,744 patent/US6605303B1/en not_active Expired - Lifetime
- 1998-12-17 UA UA2000063360A patent/UA69397C2/uk unknown
- 1998-12-17 KR KR1020007006908A patent/KR100755154B1/ko not_active IP Right Cessation
- 1998-12-17 NZ NZ505127A patent/NZ505127A/xx unknown
- 1998-12-17 EE EEP200000383A patent/EE04901B1/xx not_active IP Right Cessation
- 1998-12-17 AU AU19912/99A patent/AU759634B2/en not_active Ceased
- 1998-12-17 DK DK98964631T patent/DK1043976T3/da active
- 1998-12-17 CA CA002315261A patent/CA2315261C/en not_active Expired - Fee Related
- 1998-12-21 MY MYPI98005796A patent/MY126555A/en unknown
1999
- 1999-02-17 SA SA99191077A patent/SA99191077B1/ar unknown
2000
- 2000-06-08 IS IS5524A patent/IS5524A/is unknown
- 2000-06-08 HR HR20000380A patent/HRP20000380B1/xx not_active IP Right Cessation
- 2000-06-15 IL IL136827A patent/IL136827A/en unknown
- 2000-06-21 NO NO20003218A patent/NO20003218L/no not_active Application Discontinuation
- 2000-07-17 BG BG104620A patent/BG65028B1/bg unknown
2001
- 2001-07-19 HK HK01105069A patent/HK1034455A1/xx not_active IP Right Cessation
2006
- 2006-03-13 CY CY20061100346T patent/CY1106072T1/el unknown

Also Published As

Publication number	Publication date
RU2214232C2 (ru)	2003-10-20
CY1106072T1 (el)	2011-06-08
NO20003218L (no)	2000-08-22
NZ505127A (en)	2003-02-28
AR017201A1 (es)	2001-08-22
PL193776B1 (pl)	2007-03-30
BR9814378A (pt)	2000-10-10
AU759634B2 (en)	2003-04-17
CN1171582C (zh)	2004-10-20
SE9704869D0 (sv)	1997-12-22
HK1034455A1 (en)	2001-10-26
CZ20002314A3 (cs)	2000-11-15
TR200001981T2 (tr)	2000-11-21
ES2252875T3 (es)	2006-05-16
CN1284866A (zh)	2001-02-21
SK284988B6 (sk)	2006-04-06
TWI249410B (en)	2006-02-21
EE04901B1 (et)	2007-10-15
CZ299228B6 (cs)	2008-05-21
DK1043976T3 (da)	2006-03-20
HRP20000380B1 (en)	2007-08-31
HRP20000380A2 (en)	2001-06-30
SK8072000A3 (en)	2001-01-18
KR20060097069A (ko)	2006-09-13
HUP0101437A3 (en)	2003-01-28
US6605303B1 (en)	2003-08-12
CA2315261C (en)	2008-02-12
SA99191077B1 (ar)	2006-07-11
JP4865945B2 (ja)	2012-02-01
EP1043976B1 (en)	2005-12-14
MY126555A (en)	2006-10-31
EE200000383A (et)	2001-12-17
JP2001526211A (ja)	2001-12-18
IL136827A (en)	2007-05-15
KR20010033428A (ko)	2001-04-25
HUP0101437A2 (hu)	2001-10-28
BG104620A (en)	2001-04-30
DE69832816D1 (de)	2006-01-19
ZA9811239B (en)	1999-06-22
CA2315261A1 (en)	1999-07-01
AU1991299A (en)	1999-07-12
NO20003218D0 (no)	2000-06-21
IL136827A0 (en)	2001-06-14
BG65028B1 (bg)	2006-12-29
PL341428A1 (en)	2001-04-09
DZ2685A1 (fr)	2003-03-29
UA69397C2 (uk)	2004-09-15
KR100755154B1 (ko)	2007-09-04
EP1043976A1 (en)	2000-10-18
YU36700A (sh)	2003-01-31
MA26576A1 (fr)	2004-12-20
WO1999032091A1 (en)	1999-07-01
ATE312602T1 (de)	2005-12-15
TNSN98229A1 (fr)	2005-03-15
DE69832816T2 (de)	2006-08-31

Publication	Publication Date	Title
IS5524A (is)	2000-06-08	Forðatöflur til inntöku
IS5541A (is)	2000-06-19	Áfangatöflur til inntöku
ATE268161T1 (de)	2004-06-15	Bioadhäsive tabletten
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
ID23874A (id)	2000-05-25	Obat
DK0998272T3 (da)	2003-08-25	Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DK0966287T3 (da)	2003-08-25	Oxacarbazepinfilmovertrukne tabletter
DE69820407D1 (de)	2004-01-22	Blisterpackung
DE69824150D1 (de)	2004-07-01	Lactoferrin-tabletten
DK0981334T3 (da)	2003-09-22	Slugetabletter indeholdende paracetamol
ID23735A (id)	2000-05-11	Tablet trovafloksasin mesilat
DE59813583D1 (de)	2006-07-20	Tablettentestgerät
DK1017392T3 (da)	2002-10-21	Lægemiddel
EE9900545A (et)	2000-06-15	Farmatseutiline kompositsioon
DE59801987D1 (de)	2001-12-06	Pharmazeutische zusammensetzung enthaltend peptichemio
ATE295150T1 (de)	2005-05-15	Pharmazeutische zusammensetzungen
ID25857A (id)	2000-11-09	Komposisi farmasi
DK0994697T3 (da)	2005-02-14	Rapamycinformuleringer til oral indgivelse
ID23531A (id)	2000-04-27	Komposisi farmasi
FR2772264B1 (fr)	2000-03-03	Pilulier
UA2855S (uk)	1999-07-19	Таблетка фармацевтична
UA1246S (uk)	1996-09-30	Таблетка фармацевтична
BR1100755A (pt)	2006-05-09	composição farmacêutica
FI3862U1 (fi)	1999-03-18	Geelimuotoinen farmaseuttinen valmiste
ID21180A (id)	1999-05-06	Senyawa-senyawa farmasi